查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908540

细胞治疗原料市场规模、份额和趋势分析报告：按产品、应用、地区和细分市场预测（2026-2033 年）

Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report, By Product (Media, Sera, Antibodies, Reagents & Buffers), By End Use (CROs & CMOs, Biopharmaceutical & Pharmaceutical Companies), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

细胞治疗原料市场概览

全球细胞治疗原料市场预计到 2025 年将价值 54.7 亿美元，预计到 2033 年将达到 218.8 亿美元。

预计从 2026 年到 2033 年，该市场将以 19.15% 的复合年增长率成长。细胞培养产品（如培养基和血清）的创新，以及癌症、糖尿病和自体免疫疾病等慢性疾病的日益普遍，预计将在预测期内推动市场成长。

该报告分析了 2021 年至 2033 年各细分市场的最新趋势和收入成长预测。在本报告中，Grand View Research 根据产品、最终用途和地区对全球细胞治疗成分市场进行了细分。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数与趋势

  • 市场趋势展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析

第四章：依产品进行业务分析

  • 细胞治疗原料市场：按产品分類的波动分析
  • 细胞治疗原料市场规模及趋势分析（依产品分类，2021-2033 年）
  • 培养基
  • 血清
  • 细胞培养添加剂
  • 抗体
  • 试剂和缓衝液
  • 其他的

第五章 依最终用途进行业务分析

  • 细胞治疗材料市场：按最终用途分類的变化分析
  • 生物製药和製药公司
  • 合约研究组织 (CRO) 和合约生产组织 (CMO)
  • 其他的

第六章 区域业务分析

  • 2025年及2033年细胞治疗原料的区域市场份额
  • 北美洲
    • 2021-2033年北美细胞治疗材料市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲细胞治疗材料市场，2021-2033年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区细胞治疗材料市场，2021-2033年
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2021-2033年拉丁美洲细胞治疗材料市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2021-2033年中东及非洲细胞治疗材料市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争情势

  • 公司分类
  • 策略规划
  • 公司定位分析，2025
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Actylis.
    • ACROBiosystems
    • STEMCELL Technologies
    • Grifols, SA
    • Charles River Laboratories
    • RoosterBio, Inc.
    • PromoCell GmbH
    • Danaher
    • Sartorius Stedim BIoTech
Product Code: GVR-4-68040-137-9

Cell Therapy Raw Materials Market Summary

The global cell therapy raw materials market size was estimated at USD 5.47 billion in 2025 and is projected to reach USD 21.88 billion by 2033, growing at a CAGR of 19.15% from 2026 to 2033. Innovation in cell culture products, including media and sera, and the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders are expected to drive the market over the forecast period.

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell therapy raw materials market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Media
  • Sera
  • Cell Culture Supplements
  • Antibodies
  • Reagents & Buffers
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Others
  • Regional Outlook (Revenue, USD Million, 2021- 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising demand for cell therapies
      • 3.2.1.2. Advancements in research and development for cell-based therapies
      • 3.2.1.3. Technological Innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with the production and procurement of raw materials
      • 3.2.2.2. Stringent regulations associated with cell therapies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Cell Therapy Raw Materials Market: Product Movement Analysis
  • 4.3. Cell Therapy Raw Materials Market Size & Trend Analysis, By Product, 2021 to 2033 (USD Million)
  • 4.4. Media
    • 4.4.1. Media Market, 2021 - 2033 (USD Million)
  • 4.5. Sera
    • 4.5.1. Sera Market, 2021 - 2033 (USD Million)
  • 4.6. Cell Culture Supplements
    • 4.6.1. Cell Culture Supplements Market, 2021 - 2033 (USD Million)
  • 4.7. Antibodies
    • 4.7.1. Antibodies Market, 2021 - 2033 (USD Million)
  • 4.8. Reagents & Buffers
    • 4.8.1. Reagents & Buffers Market, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. Cell Therapy Raw Materials Market: End Use Movement Analysis
  • 5.2. Biopharmaceutical & Pharmaceutical Companies
    • 5.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
  • 5.3. CROs & CMOs
    • 5.3.1. CROs & CMOs Market, 2021 - 2033 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Cell Therapy Raw Materials Market Share By Region, 2025 & 2033
  • 6.2. North America
    • 6.2.1. North America Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Mexico Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Argentina Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Position Analysis, 2025
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Actylis.
      • 7.4.3.1. Overview
      • 7.4.3.2. Product Benchmarking
      • 7.4.3.3. Strategic Initiatives
    • 7.4.4. ACROBiosystems
      • 7.4.4.1. Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Strategic Initiatives
    • 7.4.5. STEMCELL Technologies
      • 7.4.5.1. Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Strategic Initiatives
    • 7.4.6. Grifols, S.A.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Charles River Laboratories
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. RoosterBio, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Strategic Initiatives
    • 7.4.9. PromoCell GmbH
      • 7.4.9.1. Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Strategic Initiatives
    • 7.4.10. Danaher
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Sartorius Stedim Biotech
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 Global cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 2 Global cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 3 Global cell therapy raw materials market, by region, 2021 - 2033 (USD Million)
  • Table 4 North America cell therapy raw materials market, by country, 2021 - 2033 (USD Million)
  • Table 5 North America cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 6 North America cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 8 U.S. cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 10 Canada cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Mexico cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 12 Mexico cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Europe cell therapy raw materials market, by country, 2021 - 2033 (USD Million)
  • Table 14 Europe cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 15 Europe cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 16 UK cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 17 UK cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 18 Germany cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 19 Germany cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 20 France cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 21 France cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Italy cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 23 Italy cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Spain cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 25 Spain cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Denmark cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 27 Denmark cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Sweden cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 29 Sweden cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Norway cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 31 Norway cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Asia Pacific cell therapy raw materials market, by country, 2021 - 2033 (USD Million)
  • Table 33 Asia Pacific cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Japan cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 36 Japan cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 37 China cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 38 China cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 39 India cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 40 India cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Australia cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 42 Australia cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 43 South Korea cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 44 South Korea cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Thailand cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 46 Thailand cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Latin America cell therapy raw materials market, by country, 2021 - 2033 (USD Million)
  • Table 48 Latin America cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 49 Latin America cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Brazil cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 51 Brazil cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Argentina cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 53 Argentina cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Middle East & Africa cell therapy raw materials market, by country, 2021 - 2033 (USD Million)
  • Table 55 Middle East & Africa cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 57 South Africa cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 58 South Africa cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Saudi Arabia cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 60 Saudi Arabia cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 61 UAE cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 62 UAE cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Kuwait cell therapy raw materials market, by product, 2021 - 2033 (USD Million)
  • Table 64 Kuwait cell therapy raw materials market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Cell therapy raw materials market segmentation
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Value-chain-based sizing & forecasting
  • Fig. 10 QFD modelling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Commodity flow analysis
  • Fig. 13 Market snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Segment snapshot
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Market trends & outlook
  • Fig. 18 Porter's five force analysis
  • Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
  • Fig. 20 Cell therapy raw materials market: product outlook key takeaways
  • Fig. 21 Cell therapy raw materials market: product movement analysis
  • Fig. 22 Media market, 2021-2033 (USD million)
  • Fig. 23 Sera market, 2021-2033 (USD million)
  • Fig. 24 Cell culture supplements market, 2021-2033 (USD million)
  • Fig. 25 Antibodies market, 2021-2033 (USD million)
  • Fig. 26 Reagents & buffers market, 2021-2033 (USD million)
  • Fig. 27 Others market, 2021-2033 (USD million)
  • Fig. 28 Cell therapy raw materials market: end use outlook key takeaways
  • Fig. 29 Cell therapy raw materials market: end use movement analysis
  • Fig. 30 Biopharmaceutical & pharmaceutical companies market, 2021-2033 (USD million)
  • Fig. 31 CROs & CMOs supplements market, 2021-2033 (USD million)
  • Fig. 32 Others supplements market, 2021-2033 (USD million)
  • Fig. 33 Cell therapy raw materials market revenue, by region, 2022 & 2033, (USD Million)
  • Fig. 34 Regional marketplace: key takeaways
  • Fig. 35 North America cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 U S cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 U S Key country dynamics
  • Fig. 38 Canada cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Canada Key country dynamics
  • Fig. 40 Mexico cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico Key country dynamics
  • Fig. 42 Europe cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 UK cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 UK Key country dynamics
  • Fig. 45 Germany cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Germany Key country dynamics
  • Fig. 47 France cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 France Key country dynamics
  • Fig. 49 Spain cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Spain Key country dynamics
  • Fig. 51 Italy cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Italy Key country dynamics
  • Fig. 53 Denmark cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Denmark Key country dynamics
  • Fig. 55 Sweden cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Sweden Key country dynamics
  • Fig. 57 Norway cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Norway Key country dynamics
  • Fig. 59 Asia Pacific cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Japan cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Japan Key country dynamics
  • Fig. 62 China cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 China Key country dynamics
  • Fig. 64 India cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 India Key country dynamics
  • Fig. 66 Australia cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Australia Key country dynamics
  • Fig. 68 South Korea cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 South Korea Key country dynamics
  • Fig. 70 Thailand cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Thailand Key country dynamics
  • Fig. 72 Latin America cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Brazil cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Brazil Key country dynamics
  • Fig. 75 Argentina cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Argentina Key country dynamics
  • Fig. 77 MEA cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 South Africa cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 South Africa Key country dynamics
  • Fig. 80 Saudi Arabia cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Saudi Arabia Key country dynamics
  • Fig. 82 UAE cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 UAE Key country dynamics
  • Fig. 84 Kuwait cell therapy raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Kuwait Key country dynamics